News|Articles|December 9, 2024
NGS-Based Viral Safety Testing for ATMPs: Mandatory or Just an Option?
Author(s)Charles River
NGS-Based Viral Safety Testing for ATMPs: Mandatory or Just an Option?
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Meeting Global Demand and Delivering Faster, More Reliable Service
2
A Strategic Assessment Tool for Modernizing Buffer Preparation in Biologics Facilities
3
How India’s Biotech Ecosystem Is Shifting Toward Innovation and Global Partnerships
4
Outsourcing Small Molecule Purification Processes
5
